Financial Performance - For the three months ended December 31, 2022, the total revenue was HKD 340,416,000, a decrease of 19.2% compared to HKD 421,442,000 for the same period in 2021[3] - The revenue from the distribution of cosmetic and skincare products was HKD 319,349,000, down 19.7% from HKD 397,706,000 year-on-year[3] - The operating loss for the nine months ended December 31, 2022, was HKD 18,908,000, compared to an operating profit of HKD 32,325,000 for the same period in 2021[5] - The net loss attributable to the owners of the company for the nine months ended December 31, 2022, was HKD 27,970,000, compared to a profit of HKD 19,101,000 in the previous year[5] - The company reported a total comprehensive loss of HKD 22,829,000 for the nine months ended December 31, 2022, compared to a comprehensive income of HKD 29,484,000 for the same period in 2021[7] - The company recorded a gross profit of HKD 71,396,000 for the nine months ended December 31, 2022, down 40.0% from HKD 118,829,000 in the same period of 2021[3] - The company's total revenue for the nine months ended December 31, 2022, was HKD 917,952,000, a decrease of 26.4% from HKD 1,246,596,000 in the previous year[10] - The group's revenue for the nine months ended December 31, 2022, was approximately HKD 917,952,000, a decrease of about 26% from HKD 1,246,596,000 in the same period last year[20] - The gross profit for the same period was approximately HKD 71,396,000, down 40% from HKD 118,829,000 year-on-year[21] - The group recorded a loss attributable to the owners of the company of approximately HKD 27,970,000, compared to a profit of HKD 19,101,000 in the previous year[21] - The sales of beauty and body services generated revenue of approximately HKD 31,493,000, a decrease of 40% from HKD 52,472,000 in the same period last year[21] Income and Expenses - The interest income from lending services increased to HKD 8,828,000 for the nine months ended December 31, 2022, compared to HKD 5,618,000 in the previous year, reflecting a growth of 57.5%[10] - The total other income for the nine months ended December 31, 2022, was HKD 5,387,000, significantly higher than HKD 1,879,000 in the previous year[12] - The basic loss per share for the nine months ended December 31, 2022, was HKD (36.32), compared to earnings of HKD 25.45 in the same period of 2021[5] - The group experienced a net loss of approximately HKD 796,000 from investments in the Hong Kong stock market and unlisted equity funds, compared to a net gain of approximately HKD 16,856,000 in the previous year[20] - The company recorded a net loss of approximately HKD 796,000 from financial assets measured at fair value, compared to a net gain of HKD 16,856,000 in the previous year[30] Market Conditions - The economic slowdown in Hong Kong and China, along with the impact of the COVID-19 pandemic, has negatively affected consumer confidence and the group's overall performance[23] - The distribution revenue in China decreased to approximately HKD 876,862,000, down from HKD 1,170,328,000 in the previous year, reflecting the ongoing impact of COVID-19 on the economy[26] - The company anticipates a rebound in sales performance in the foreseeable future as COVID-19 restrictions are eased[26] Strategic Initiatives - The company aims to introduce advanced and high-quality services and products to enhance customer loyalty and brand image in the beauty and wellness sector[23] - The company plans to continue launching safe and effective products to meet diverse customer needs, enhancing the attractiveness of the "修身堂" brand[27] - The company is focusing on prudent management of property acquisitions and renovations due to current market uncertainties[35] - The company aims to leverage its brand strength and professional services to capture a larger share of the high-end market[24] - The company is committed to investing in advanced technology and safe ingredients for its health and beauty product offerings[27] Shareholder Information - As of December 31, 2022, the company has granted stock options totaling 5,253,458 shares under its stock option plan, with a weighted average exercise price of HKD 0.87 per share[38] - Major shareholder Qiu Zhongzong holds 10,979,000 shares, representing 13.93% of the company's issued share capital as of December 31, 2022[40] - The stock options granted to directors and key executives include a total of 2,251,482 shares for directors and 750,494 shares for the CEO, all with an exercise price of HKD 0.87[38] - The average remaining contractual life of the stock options is approximately 3.87 years[38] - The company has established a formal and transparent procedure to protect shareholder interests, adhering to the GEM Listing Rules[44] - No directors or major shareholders have any interests in businesses that compete or may compete with the company's operations[43] Governance and Compliance - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited financial performance for the three and nine months ending December 31, 2022[46] - The company has confirmed that all directors have complied with the trading standards set out in the GEM Listing Rules[48] - The board did not recommend an interim dividend for the nine months ended December 31, 2022, compared to no dividend in the previous year[19] - The company has not purchased, redeemed, or sold any of its listed securities during the nine months ending December 31, 2022[49] - The company has not disclosed any new strategies related to market expansion or mergers and acquisitions in the provided documents[39]
修身堂(08200) - 2023 Q3 - 季度财报